Robin Wiltshire
Robin Wiltshire publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Lung Cancer Diagnosis and Treatment.
- World rank
- #2,131,344 of 7,710,434 ranked researchers
- Rank in United States
- #642,144 of 1,627,098
- Works
- 23
- Citations
- 1.1k
- Citations per work
- 48.8
What does Robin Wiltshire research?
Robin Wiltshire's work is mostly in Medicine (76%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1876.4%
- Medicine1876.4%
- Everything else311.9%
- Life Sciences311.7%
- 1Pulmonary and Respiratory Medicine48% of their works
- 2Oncology22% of their works
- 3Cancer Research9% of their works
- 4Gastroenterology3% of their works
- 5Epidemiology3% of their works
- 6Molecular Biology3% of their works
Research topics
Which keywords describe Robin Wiltshire's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Prognostic Factors and Adjuvant Therapy.
- Fatty Acid Synthase
- Cetuximab
- Gastric Cancer
- Cancer Genomics
- Metastatic
- CT Screening
- Genomic Profiles
- Adjuvant Therapy
- Immunotherapy
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- Prognostic Factors
- Molecular Characterization
- Small-Cell Lung Cancer
- Lung Cancer
- Renal Cell Carcinoma
- Endoscopic Resection
- Mutational Signatures
- KRAS Mutations
- Lipid Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Targeted Therapy273 topics
- Clinical Trials232 topics
- Chemotherapy214 topics
- ALK Inhibitors151 topic
- EGFR Mutations151 topic
- Immunotherapy132 topics
- Prognostic Factors132 topics
- Adjuvant Therapy102 topics
- Molecular Characterization92 topics
- Genomic Profiles81 topic
- Small-Cell Lung Cancer81 topic
- CT Screening61 topic
- Lung Cancer61 topic
- Metastatic51 topic
- Renal Cell Carcinoma51 topic
- Cancer Genomics41 topic
- Endoscopic Resection41 topic
- Gastric Cancer41 topic
- Mutational Signatures41 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Fatty Acid Synthase21 topic
- Lipid Metabolism21 topic
Where does Robin Wiltshire work?
Robin Wiltshire's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Robin Wiltshire have?
OpenAlex counts 23 works and 1,123 citations for Robin Wiltshire, an h-index of 11, ranking #2,131,344 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Robin Wiltshire. Posts are plain text and can be reported.